CUE
Cue Biopharma
27.50$
-12.6%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Cash Flow
Cue Biopharma (CUE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -22 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.7 | -6.0 | -12 | -26 | -31 | -32 | -39 | -42 | -40 | -36 | -22 | |
| 0.0 | 0.2 | 0.4 | 0.8 | 5.2 | -3.1 | -1.8 | 1.8 | 3.4 | 2.4 | 1.0 | |
| – | 0.9 | 2.8 | 7.2 | 6.5 | 10 | 12 | 9.5 | 8.2 | 6.8 | 4.7 | |
| 0.1 | 1.0 | 7.7 | 7.5 | 6.6 | 9.9 | 11 | 9.5 | – | – | – | |
| 0.1 | 0.5 | 2.9 | 4.2 | -1.5 | 5.4 | -4.4 | 0.4 | -0.9 | -4.9 | -3.3 | |
| 0.8 | 0.5 | 1.2 | 1.9 | 0.0 | 0.6 | 0.9 | 0.2 | 0.0 | 0.1 | 0.2 | |
| -0.8 | -0.5 | -1.2 | -20 | 3.4 | 4.5 | 9.1 | -25 | 25 | 0.0 | 0.1 | |
| – | – | – | – | – | – | – | 0.2 | – | – | – | |
| -1.1 | -1.4 | -4.2 | 4.2 | -0.1 | -0.3 | -0.8 | -0.2 | – | – | – | |
| – | – | – | – | 10 | 10 | 10 | 15 | -2.0 | -4.0 | -4.5 | |
| 8.9 | 15 | 62 | 4.2 | 51 | 59 | 19 | 54 | 12 | 10 | 26 | |
| 6.4 | 8.5 | 49 | -43 | 23 | 31 | -10 | -13 | -3.1 | -26 | 4.7 | |
| -2.4 | -6.5 | -13 | -28 | -31 | -33 | -40 | -42 | -40 | -36 | -22 |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.